Even biopharma’s biggest players have been forced to take a hard look at their businesses and realign their cost structures to cope with the continued and compounding challenges plaguing the industry.
Big Pharma restructures to ride out ‘existential risk’ Read More »
While merger and acquisition activity has been robust of late, frequent changes in guidance and leadership at the regulator add risk to any transaction.
Florence Chang, a long-time executive of the Washington-based nonprofit, will replace current CEO William Robertson on Jan. 1.
Divakar Ramakrishnan brings experience from Convatec and Eli Lilly. Insulet said the new hire was an important step in strengthening the company’s innovation capabilities.
Insulet hires first chief R&D officer amid growing competition Read More »
Eric Lenard comes to the new position with more than two decades of experience in medtech finance, as Medtronic steps up its investment in innovation.
Medtronic appoints veteran J&J exec as first CFO of innovation Read More »
Dr. Michael Cuffe, who assumed the role in 2022, is leaving at the end of August.
HCA’s chief clinical officer to exit after 4 years Read More »
Todas las células de los animales, las plantas, los hongos y los protistas comparten una característica fundamental: son células eucariotas, es decir, células complejas, con compartimentos internos especializados. También lo son las células que forman nuestr …
Replantean el origen de nuestras células como una historia de alianzas microbianas Read More »
Unos científicos han creado un sistema biotecnológico para la vigilancia y control de plagas y enfermedades en los cultivos agrícolas que se basa en plantas modificadas para brillar de maneras específicas. Utilizando un mecanismo de emisión de luz inspirado en hong …
As Sangamo runs out of cash, Eli Lilly and Astellas have emerged as stalking horse bidders for key assets, including a Fabry gene therapy currently being submitted for potential FDA approval.
Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy Read More »
Los nanorrobots pueden parecer más ciencia-ficción que realidad, pero lo cierto es que la nanorrobótica se ha convertido en un campo de investigación que registra avances a buen ritmo. Usar nanorrobots se considera un enfoque prometedor para, por ejemplo, administrar sust …
